Xiaoxiao Liu
6PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 27, 2025
Polatuzumab Vedotin Induced CD20 Upregulation Contributes to the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma Preclinical Models.Natsumi Kawasaki, Sei Shu, Mayu Tomita
|Dec 09, 2024
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity.Naru Sato, Susumu Goyama, Yu-Hsuan Chang
|Dec 01, 2022
IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia.Xiaoxiao Liu, Naru Sato, Tomohiro Yabushita
|Feb 08, 2022
CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression.Xiaoxiao Liu, Naru Sato, Yuko Shimosato
|Oct 27, 2019
Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia.Yasutaka Hayashi, Susumu Goyama, XiaoXiao Liu
|Jun 05, 2019
Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms.Moe Tamura, Taishi Yonezawa, Xiaoxiao Liu
Pageof 1
Frequent Collaborators
4 joint publications
Shuhei Asada
3 joint publications
Tomofusa Fukuyama
2 joint publications
Naru Sato
2 joint publications
Susumu Goyama
1 joint publications
Koichi Matsuda
1 joint publications
Goro Sashida
1 joint publications
Hiroyuki Iwamura
1 joint publications
Kensuke Komatsu
1 joint publications
Hitoshi Takizawa
1 joint publications
Koji Ueda
